Archive · 13 Jun 2025
Prior COVID Vaccination Improves Outcomes for AKI Patients
A new study found that if people with COVID-19 get a kidney problem called acute kidney injury (AKI), the ones who had gotten a COVID-19 vaccine did better than those who didn't.
They were less likely to need a special treatment called dialysis, and they were more likely to live.
Researchers looked at a lot of patients who had been in the hospital with COVID-19.
They found that the vaccine helped protect the kidneys.
The doctors say getting the COVID-19 vaccine is a good idea, because it can help people avoid serious kidney problems, and the need for dialysis and helps them live longer.
Study shows vaccinated COVID-19 patients with acute kidney injury (AKI) had better outcomes.
Vaccinated patients were less likely to need dialysis or die compared to unvaccinated patients.
Researchers analyzed 3,500 hospitalized COVID-19 patients between March 2020 and March 2022.
46% of COVID-19 patients develop AKI, which can lead to dialysis.
The study highlights the benefits of COVID-19 vaccination for patients with AKI.
- Who
- Researchers from UCLA led the study; Patients hospitalized with COVID-19 and AKI were studied.
- What
- Study shows vaccinated COVID-19 patients with acute kidney injury (AKI) had better outcomes.
- When
- Study analyzed patients between March 1, 2020, and March 30, 2022.
- Where
- University of California-Los Angeles (UCLA) led the research.
- Why
- To understand the long-term renal and survival outcomes of COVID-19 patients with AKI and the impact of vaccination.
- Study Focus
- Impact of COVID-19 vaccination on patients with AKI
- AKI prevalence
- Up to 46% in COVID-19 patients
- Vaccination Types
- Pfizer, Moderna, or Johnson & Johnson
- Unvaccinated needing CRRT
- 15.8%
- Vaccinated needing CRRT
- 10.9%
- Unvaccinated patients mortality risk
- 5.54 times higher in the hospital
- Unvaccinated patients mortality risk (follow-up)
- 4.78 times higher